Michael R Megna's Securities Transactions and Plan Adoption

The filing details the securities transactions of Michael R Megna, an officer at Kiniksa Pharmaceuticals International, plc. The transactions include the exercise of employee stock options, restricted stock lapses, and ESPP shares. The employee stock options were exercised on 10/20/2025, resulting in the acquisition of 39,435 Class A ordinary shares. Restricted stock lapses occurred from 9/1/2025 to 10/04/2025, acquiring 5,060 Class A ordinary shares. ESPP shares were acquired from 06/28/2019 to 01/15/2024, totaling 5,995 Class A ordinary shares. Additionally, the filing reports recent sales of securities, including 17,000 shares sold on 08/04/2025 for $549,936 and 11,000 shares sold on 09/03/2025 for $383,203. The plan adoption date is noted as 05/24/2025.